Castillo-Riquelme M , 2017. Chagas disease in non-endemic countries. Lancet Glob Health 5: e379–e380.
Monge-Maillo B , López-Vélez R , 2017. Challenges in the management of Chagas disease in Latin-American migrants in Europe. Clin Microbiol Infect 23: 290–295.
Requena-Méndez A , Bussion S , Aldasoro E , Jackson Y , Angheben A , Moore D , Pinazo MJ , Gascón J , Muñoz J , Sicuri E , 2017. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. Lancet Glob Health 5: e439–e447.
Ministerio de Sanidad , 2020. Equidad en Salud y COVID-19: Análisis y propuestas para abordar la vulnerabilidad epidemiológica vinculada a las desigualdades sociales. Available at: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Equidad_en_salud_y_COVID-19.pdf. Accessed October 28, 2021.
Navarro M , Reguero L , Subirà C , Blázquez-Pérez A , Requena-Méndez A , 2022. Estimating Chagas disease prevalence and number of underdiagnosed, and undertreated individuals in Spain. Travel Med Infect Dis 47: 102284.
Muñoz-Vilches MJ , Salas-Coronas J , Gutiérrez-Izquierdo MI , Metz D , Salvador-Sánchez J , Giménez-Sánchez F , 2013. Health professionals’ knowledge on Chagas disease in the province of Almeria, Spain [in Spanish]. Rev Esp Salud Pública 87: 267–275.
Claveria Guiu I , Caro Mendivelso J , Ouaarab Essadek H , González Mestre MA , Albajar-Viñas P , Gómez I Prat J , 2017. The Catalonian Expert Patient Programme for Chagas disease: an approach to comprehensive care involving affected individuals. J Immigr Minor Health 19: 80–90.
Ramos-Rincón JM , Mira-Solves JJ , Ramos-Sesma V , Torrús-Tendero D , Llenas-García J , Navarro M , 2020. Healthcare professionals and students’ awareness of Chagas disease: design and validation of Chagas Level of Knowledge Scale (ChaLKS). Am J Trop Med Hyg 103: 437–444.
Amstutz-Szalay S , 2017. Physician knowledge of Chagas disease in Hispanic immigrants living in Appalachian Ohio. J Racial Ethn Health Disparities 4: 523–528.
Stimpert KK , Montgomery SP , 2010. Physician awareness of Chagas disease. USA Emerg Infect Dis 16: 871–872.
Soares Cajaiba-Soares AM , Martinez-Silveira MS , Paim Miranda DL , de Cássia Pereira Fernandes R , Reis MG , 2021. Healthcare workers’ knowledge about Chagas disease: a systematic review. Am J Trop Med Hyg 104: 1631–1638.
Ramos-Rincon JM , Llenas-García J , Pinargote-Celorio H , Sánchez-García V , Wikman-Jorgensen P , Navarro M , Gil-Anguita C , Ramos-Sesma V , Torrus-Tendero D , 2021. Chagas disease-related mortality in Spain, 1997 to 2018. Microorganisms 9: 1991.
Roger D , González-Escalada A , Navarro M , 2017. Evaluación del Conocimiento sobre Enfermedades Tropicales Desatendidas en Estudiantes de Sexto Curso del Grado en Medicina de la Comunidad Autónoma de Madrid. X Congreso Nacional de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI). October 25–27, 2017, Bilbao, Spain.
Sequeira-Aymar E , 2020. Migration and screenings [article in Spanish]. Aten Primaria 52: 221–223.
Simón M , Iborra MA , Carrilero B , Romay-Barja M , Vázquez C , Gil-Gallardo LJ , Segovia M , 2020. The clinical and parasitologic follow-up of Trypanosoma cruzi-infected children in a nonendemic country. Pediatr Infect Dis J 39: 494–499.
Sulleiro E et al., 2020. Usefulness of real-time PCR during follow-up of patients treated with benznidazole for chronic Chagas disease: experience in two referral centers in Barcelona. PLoS Negl Trop Dis 14: e0008067.
Pinheiro E , Brum-Soares L , Reis R , Cubides JC , 2017. Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America. Rev Soc Bras Med Trop 50: 296–300.
Moscatelli G et al., 2015. Urban Chagas disease in children and women in primary care centres in Buenos Aires, Argentina. Mem Inst Oswaldo Cruz 110: 644–648.
Crespillo-Andújar C , Chamorro-Tojeiro S , Norman F , Monge-Maillo B , López-Vélez R , Pérez-Molina JA , 2018. Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail. Clin Microbiol Infect 24: 1344.e1–1344.e4.
Pérez-Molina JA , Crespillo-Andújar C , Bosch-Nicolau P , Molina I , 2020. Trypanocidal treatment of Chagas disease. Enferm Infecc Microbiol Clin (Engl Ed) 39: 458–470.
Navarro M , Carrillo Acosta I , Herrero-Martínez JM , Calderón-Moreno M , Martín-Rabadán P , Trigo E , 2021. Advocating for a comprehensive care and control of Chagas disease in Madrid, Spain. Casebook for Advocacy in Public Health. Geneva, Switzerland: World Federation of Public Health Associations, 144–157.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 366 | 366 | 55 |
Full Text Views | 587 | 587 | 2 |
PDF Downloads | 77 | 77 | 4 |
Chagas disease (CD) is a parasitic disease endemic to continental Latin America that has globalized in recent years. The most relevant mechanisms of transmission of CD in non-endemic countries are transfusion with infected blood and mother-to-child transmission. There is limited information regarding practicing physicians’ knowledge of CD transmission, clinical presentation, and treatment in non-endemic countries, including Spain. Our objective was to analyze the level of knowledge about CD in family and community medicine residents and how it has evolved over the last 5 years. A cross-sectional study was performed in the framework of the training program for family and community medicine specialists in Alicante, Spain. Convenience sampling was used to enroll 214 fourth-year family and community medicine residents from 2016 to 2020. Participants completed the validated Chagas Level of Knowledge Scale questionnaire prior to attending the seminar “Health Care for the Immigrant Population.” The mean score on the scale was 7.1/10 points. Only 12 participants (5.6%) answered all questions correctly. Resident physicians who reported having received prior information on CD scored better than those who were not informed (mean, 7.2 versus 6.1 points). Participants from Latin America had scores similar to those of the rest of the participants. Over the 5-year study period, questionnaire scores tended to increase. Knowledge about CD among family and community medicine residents has improved in recent years, although it is still not optimal. Specific training on CD during specialized health care training is warranted.
Authors’ addresses: José-Manuel Ramos-Rincón, Clinical Medicine Department, Miguel Hernández University of Elche, Alicante, Spain, E-mail: jose.ramosr@umh.es. José-Joaquín Mira-Solves, Health Psychology Department, Miguel Hernández University of Elche, Alicante, Spain, E-mail: jose.mira@umh.es. Patricia Crespo-Mateos, Milagros Oyarzabal, and Clara-Isabel Pérez-Ortiz, Multiprofessional Teaching Unit for Alicante Family and Community Medicine, Alicante, Spain, E-mails: anapatriciacrespo@gmail.com, oyarzabal_mil@gva.es, and udalicante@gva.es. Violeta Ramos-Sesma, Internal Medicine Department, Hospital HLA Inmaculada, Granada, Spain, E-mail: vramossesma@gmail.com. Miriam Navarro, Unit of Epidemiology, Public Health Centre of Elche, Alicante, Spain, and Public Health, Science History and Gynecology Department, Miguel Hernández University of Elche, Alicante, Spain, E-mail: navarro_mirbel@gva.es.
Castillo-Riquelme M , 2017. Chagas disease in non-endemic countries. Lancet Glob Health 5: e379–e380.
Monge-Maillo B , López-Vélez R , 2017. Challenges in the management of Chagas disease in Latin-American migrants in Europe. Clin Microbiol Infect 23: 290–295.
Requena-Méndez A , Bussion S , Aldasoro E , Jackson Y , Angheben A , Moore D , Pinazo MJ , Gascón J , Muñoz J , Sicuri E , 2017. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. Lancet Glob Health 5: e439–e447.
Ministerio de Sanidad , 2020. Equidad en Salud y COVID-19: Análisis y propuestas para abordar la vulnerabilidad epidemiológica vinculada a las desigualdades sociales. Available at: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Equidad_en_salud_y_COVID-19.pdf. Accessed October 28, 2021.
Navarro M , Reguero L , Subirà C , Blázquez-Pérez A , Requena-Méndez A , 2022. Estimating Chagas disease prevalence and number of underdiagnosed, and undertreated individuals in Spain. Travel Med Infect Dis 47: 102284.
Muñoz-Vilches MJ , Salas-Coronas J , Gutiérrez-Izquierdo MI , Metz D , Salvador-Sánchez J , Giménez-Sánchez F , 2013. Health professionals’ knowledge on Chagas disease in the province of Almeria, Spain [in Spanish]. Rev Esp Salud Pública 87: 267–275.
Claveria Guiu I , Caro Mendivelso J , Ouaarab Essadek H , González Mestre MA , Albajar-Viñas P , Gómez I Prat J , 2017. The Catalonian Expert Patient Programme for Chagas disease: an approach to comprehensive care involving affected individuals. J Immigr Minor Health 19: 80–90.
Ramos-Rincón JM , Mira-Solves JJ , Ramos-Sesma V , Torrús-Tendero D , Llenas-García J , Navarro M , 2020. Healthcare professionals and students’ awareness of Chagas disease: design and validation of Chagas Level of Knowledge Scale (ChaLKS). Am J Trop Med Hyg 103: 437–444.
Amstutz-Szalay S , 2017. Physician knowledge of Chagas disease in Hispanic immigrants living in Appalachian Ohio. J Racial Ethn Health Disparities 4: 523–528.
Stimpert KK , Montgomery SP , 2010. Physician awareness of Chagas disease. USA Emerg Infect Dis 16: 871–872.
Soares Cajaiba-Soares AM , Martinez-Silveira MS , Paim Miranda DL , de Cássia Pereira Fernandes R , Reis MG , 2021. Healthcare workers’ knowledge about Chagas disease: a systematic review. Am J Trop Med Hyg 104: 1631–1638.
Ramos-Rincon JM , Llenas-García J , Pinargote-Celorio H , Sánchez-García V , Wikman-Jorgensen P , Navarro M , Gil-Anguita C , Ramos-Sesma V , Torrus-Tendero D , 2021. Chagas disease-related mortality in Spain, 1997 to 2018. Microorganisms 9: 1991.
Roger D , González-Escalada A , Navarro M , 2017. Evaluación del Conocimiento sobre Enfermedades Tropicales Desatendidas en Estudiantes de Sexto Curso del Grado en Medicina de la Comunidad Autónoma de Madrid. X Congreso Nacional de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI). October 25–27, 2017, Bilbao, Spain.
Sequeira-Aymar E , 2020. Migration and screenings [article in Spanish]. Aten Primaria 52: 221–223.
Simón M , Iborra MA , Carrilero B , Romay-Barja M , Vázquez C , Gil-Gallardo LJ , Segovia M , 2020. The clinical and parasitologic follow-up of Trypanosoma cruzi-infected children in a nonendemic country. Pediatr Infect Dis J 39: 494–499.
Sulleiro E et al., 2020. Usefulness of real-time PCR during follow-up of patients treated with benznidazole for chronic Chagas disease: experience in two referral centers in Barcelona. PLoS Negl Trop Dis 14: e0008067.
Pinheiro E , Brum-Soares L , Reis R , Cubides JC , 2017. Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America. Rev Soc Bras Med Trop 50: 296–300.
Moscatelli G et al., 2015. Urban Chagas disease in children and women in primary care centres in Buenos Aires, Argentina. Mem Inst Oswaldo Cruz 110: 644–648.
Crespillo-Andújar C , Chamorro-Tojeiro S , Norman F , Monge-Maillo B , López-Vélez R , Pérez-Molina JA , 2018. Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail. Clin Microbiol Infect 24: 1344.e1–1344.e4.
Pérez-Molina JA , Crespillo-Andújar C , Bosch-Nicolau P , Molina I , 2020. Trypanocidal treatment of Chagas disease. Enferm Infecc Microbiol Clin (Engl Ed) 39: 458–470.
Navarro M , Carrillo Acosta I , Herrero-Martínez JM , Calderón-Moreno M , Martín-Rabadán P , Trigo E , 2021. Advocating for a comprehensive care and control of Chagas disease in Madrid, Spain. Casebook for Advocacy in Public Health. Geneva, Switzerland: World Federation of Public Health Associations, 144–157.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 366 | 366 | 55 |
Full Text Views | 587 | 587 | 2 |
PDF Downloads | 77 | 77 | 4 |